M&A Deal Summary

Charles River Laboratories International Acquires Accugenix

On August 29, 2012, Charles River Laboratories International acquired life science company Accugenix for 17M USD

Acquisition Highlights
  • This is Charles River Laboratories International’s 6th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 16th largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 5th transaction in the United States.
  • This is Charles River Laboratories International’s 1st transaction in Delaware.

M&A Deal Summary
Date 2012-08-29
Target Accugenix
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition
Deal Value 17M USD
Advisor(s) Fairmount Partners (Financial)

Target

Accugenix

Newark, Delaware, United States
Accugenix is a provider of cGMP compliant contract microbial testing service laboratory over the past 20 years, specializing in bacterial and fungal identification and strain typing of environmental isolates.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States
Category Company
Founded 1947
Sector Life Science
Employees20,400
Revenue 4.1B USD (2023)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.

DEAL STATS #
Overall 7 of 31
Sector (Life Science) 6 of 28
Type (Add-on Acquisition) 6 of 26
State (Delaware) 1 of 1
Country (United States) 5 of 20
Year (2012) 1 of 1
Size (of disclosed) 16 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-01 Systems Pathology

Seattle, Washington, United States

Systems Pathology Co. LLC is a pathology based software development company focused on developing analytical imaging technologies to automate the labor-intensive tissue evaluations process, which is a significant component of standard pre-clinical studies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 Vital River Laboratories

Beijing, China

Vital River Laboratories Co. Ltd. is a provider of research models and related services in China.

Buy -
Mergr

Product

Company

Legal